Virtual Medicinal Product (VMP) - Fluticasone propionate 250micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler

Navigation

Name Details

Name Start Date End Date
Name Current Name Fluticasone propionate 250micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Start Date 01-01-2014 End Date
Previous Name Previous Name Fluticasone 250micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler Start Date 15-08-2006 End Date 31-12-2013
Abbreviated Name Abbreviated Name Fluticasone propionate 250microg/Salmeterol 50microg/dose Start Date 01-01-2014
Previous Abbreviated Name Fluticasone 250microg / Salmeterol 50microg/dose dry pdr inh Previous Start Date 15-08-2006 Previous End Date 31-12-2013

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
dose
Unit Dose UOM
dose

Summary

Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
No Controlled Drug Status
Route
Inhalation
Form
Inhalation powder
Ontology Form/Route
powderinhalation.inhalation
Name Basis
Other

Codes

ATC Code
R03AK06
BNF Start Date End Date
Current BNF 03020000 Start Date 04-04-2022 End Date
Previous BNF 03020000 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
38897511000001104 19-08-2020
320279002 16-12-2002 18-08-2020

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Fluticasone propionate Based on Ingredient Substance 250 microgram 1 dose
Salmeterol xinafoate Based on Base Substance Salmeterol 50 microgram 1 dose

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
60 dose 3395 Part VIIIA Category C